Delivery Order SPE2DB22D1002-SPE2DB24FKXQ5

Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide PEDIARIX 0.5ML syringes. The $15,902.20 delivery order has a completion date of February 6, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceuticals and medical supplies to U.S. government agencies, including the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PEDIARIX 0.5 ML SYRINGE 0.5ML. The total potential value of this order is $3,210.65, with a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $12,323.40 to Amerisourcebergen Drug Corp for the supply of 0.5 mL PEDIARIX vaccine syringes. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has a completion date of February 6, 2024 and a potential value of $4,317.70. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not part of a larger contract vehicle. No set-aside designation was used for this award. Amerisourcebergen Drug...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $1,526.44 by the Defense Logistics Agency (DLA) to provide PEDIARIX 0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, supplying a range of pharmaceuticals and medical supplies in support of military treatment programs and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $5,609.30 contract is for the provision of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through December 2025....
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $2,776.41 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has no set-aside designation, is for the delivery of the pharmaceutical product PEDIARIX 0.5 ML SYRINGE 0.5ML. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, also holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The $1,387.88 award has a completion date of February 12, 2024 and was issued on February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with a larger contract vehicle. No set-aside designation was used for this award....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 0.5 milliliter syringes of the pharmaceutical product PEDIARIX. The $4,574.88 order, placed on January 9, 2024, is set to be completed by January 10, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a range of pharmaceuticals and medical supplies to support DLA Troop Support Medical programs. This delivery order...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide PEDIARIX 0.5 ML SYRINGE 0.5ML pharmaceuticals. The contract has a potential value of $1,680.82 and a completion date of February 28, 2024. This award is not associated with any set-aside programs. Amerisourcebergen Drug Corp serves as the prime contractor, providing a range of pharmaceutical products and medical...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FKXQ5
    Delivery Order

The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $7,239.64, is for the provision of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of February 7, 2024. Amerisourcebergen Drug Corp, as the prime contractor, provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.

Generated 5/7/24, 11:39 AM